EichorEICHOR
Condition: Lca Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Lca

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Carbon Footprint Assessment for Robotic, Laparoscopic and Open Colorectal Operations to Enhance Environmental Sustainabi
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT06844604The CARBO CARBON Study
Phase N/A · 1 location(s) · Karolinska Institutet · NCT07521943Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Phase 3 · 17 location(s) · Laboratoires Thea · NCT06891443Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interv
Phase 1/Phase 2 · 2 location(s) · Opus Genetics, Inc · NCT05616793Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)
Phase 1/Phase 2 · 3 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT05906953
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.